General - AI News today

Where Are All the AI Drugs?

wired.com • Yesterday

In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting everything on AI to beat the odd...

TL;DR

Artificial intelligence (AI) is revolutionizing the drug discovery process, enabling faster and cheaper development of new medications, but it also raises concerns about job displacement and the ethics of using AI to design medicines.

Key Takeaways:

More than 90% of AI-designed molecules fail during the clinical trials process, despite showing promise in preclinical research.
Companies like Recursion and Insilico are working to refine their AI-driven approaches to drug discovery, but the results are still uncertain and may take years to realize.
The use of AI in drug design and discovery may displace human chemists and biologists, as the automation of laboratory processes accelerates.

UAE’s deal to buy Nvidia AI chips reportedly on hold

techcrunch.com • Yesterday

The U.S. is reportedly holding up the deal due to concerns that AI chips could be smuggled to China from the UAE....

TL;DR

UAE's massive AI chip deal with the US is on hold due to national security concerns that the chips may end up in China.

Key Takeaways:

US officials are concerned that AI chips could be smuggled to China, exacerbating existing concerns.
The Trump administration is considering imposing chip export restrictions on Thailand and Malaysia to curb smuggling.
Malaysia has recently introduced export permit requirements for US AI chips.

The creepy AI era is here

theverge.com • 15h ago

Would you like Siri more if it had a face? Ever since Elon Musk added a weird anime girlfriend to Grok, I've been wondering if there's a not-so-distan...

Perplexity’s CEO on why the browser is AI’s killer app

theverge.com • Yesterday

Hello, and welcome to Decoder! I’m Alex Heath, deputy editor at The Verge and author of the Command Line newsletter. I’m hosting our Thursday episodes...